Translate page

Mauro NaranieDuring our iCMLf Conversation on May 28th, Professor Michael Mauro will provide you with an update on the iCMLf COVID-19 and CML data collection and what we’ve learnt so far.
On the webinar Dr Naranie Shanmunagathan will also share with you first results from our COVID-19 vaccine patient perception study.

iCMLf Conversation on CML: CML and COVID-19. What do we know so far?

May 28th at 7.00 Eastern Standard Time / 13.00 Central European Time

CD5038 Conversations tile 27x128 

The iCMLf is hosting monthly 'iCMLf Conversations on CML' with expert live discussions on various topics in CML management. On this page you will find recordings from past conversations with renowned CML experts that cover a wide range of topics like;

  • CML and COVID-19: What do we know so far?
  • Treatment-free remission in children with CML
  • COVID-19 vaccines and CML
  • Virtual iCMLf Forum: Meet-the-expert Session
  • CML highlights from ASH 2020
  • Treatment-free remission
  • Current research in CML
  • 2020 ELN recommendations

Watch out for more expert discussions in the next couple of weeks.

Mauro Naranie

Panel of experts:

Professor Michael Mauro
Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine,
New York (USA)

Dr Naranie Shanmuganathan
Royal Hospital and SA Pathology,
Adelaide (Australia)

Millot EHA 2019 
Professor Fréderic Millot
University of Poitiers, Poitiers (France)

    Collage Wesseling Sweet 2

Panel of experts:

Professor Steve Wesselingh
South Australia Health and Medical Research Institute, Adelaide (Australia)

Dr Kendra Sweet
Haematologist at the MOFFITT Cancer Center and Research Institute, Tampa (USA)